ClinicalTrials.gg
CompletedNCT07020234Updated Oct 14, 2026Results posted

National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics

An interventional study of Epigenetics Video and Nanotechnology Video in Healthy, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Other

How we know

Updated Oct 14, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,040
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 585 studies in Behavior with a site in United States — 87 open to participants now, 118 under way, 2 of them phase 3. Behavior · United States.

Enrollment
39th of 495
2,040 · median 121
Started
2025
with 33 others
No phase
431 of 585
74 open now
Registered
545th of 585
by date

Among the 585 studies in Behavior with a site in United States, this one is the 39th largest by enrollment of the 495 interventional ones that give a count, is one of 34 that started in 2025, is one of 431 with no phase, and was the 545th registered.

Behavior

1,579 studies on the registry are indexed under Behavior; 314 are open to participants now.

Browse Behavior studies →

Open to participants now

87 of the 585 studies in Behavior with a site in United States are open now. Recruiting first, the newest first:

82 more — sign in →

All 87 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 177 Behavior studies recruiting now, 77 (44%) set no upper age limit and 72 (41%) stop at 75 or younger; 58 take children under 18; 99 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 585 studies in Behavior with a site in United States, or all of them as a file.
02

Study summary

Few people realize that environmental pollution and some behaviors like physical activity and tobacco smoking can affect their health by "turning on" or "turning off" certain genes through a process called "epigenetic modification." This study will develop and test strategies for communicating about epigenetics that are understandable and that increase acceptance of using epigenetics in clinical settings.

03

Conditions studied

  • Healthy

Browse trials for

Keywords

  • Epigenomics
  • Epigenetics
  • Genetics, Behavioral
  • Bioethics
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

English language speaker,

Identify as one of five racial/ethnic groups:

  1. Non-Hispanic White
  2. Non-Hispanic Black,
  3. Non-Hispanic Asian
  4. Non-Hispanic Indigenous (i.e., Alaska Native/Native Hawaiians/American Indian/Other Pacific Islander)
  5. Hispanic (all races)

Exclusion criteria

Exclusion Criteria:

  • Self-identify as a genetics expert
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,040 participants (actual)

Study arms

  • Experimental
    Epigenetics Video

    Participants will watch a brief (\<5 minute) video about the concept of Epigenetics

    Behavioral: Epigenetics Video

  • Active comparator
    Nanotechnology Video

    Participants will watch a brief (\<5 minute) video about nanotechnology

    Behavioral: Nanotechnology Video

Interventions

  • BehavioralEpigenetics Video

    Educational video about health and epigenetics.

  • BehavioralNanotechnology Video

    Educational video about nanotechnology

06

What researchers measure

Primary outcomes

  1. Knowledge & Understanding of Epigenetics Information

    We will measure this outcome using a sum score of correct answers for 8 individual items. Scale ranges from 0 points to 8 points with higher scores indicating higher epigenetics knowledge.

    Time frame: After intervention video

Secondary outcomes

  1. Acceptability of Epigenetics Information

    We will measure this outcome using 3 different constructs including perceived benefits of epigenetic research (items 1-7, ranging from 1 to 5 with higher scores indicating higher perceived benefits), perceived drawbacks of epigenetic research (items 8-10, ranging from 1 to 5 with higher scores indicating higher perceived drawbacks), and acceptance of using epigenetic research in medical support (items 11-13, ranging from 1 to 5 with higher scores indicating higher acceptance of using epigenetic research in medical support). Each item was analyzed separately.

    Time frame: After intervention video

  2. Perceptions of Epigenetic Information

    We will measure this outcome using an 6 item scale. Scores range from 1 to 5, with higher scores indicating greater perceptions of epigenetic information.

    Time frame: After intervention video

07

Results

Posted Oct 14, 2026

Participant flow

Participant flow — Overall Study
MilestoneEpigenetics VideoNanotechnology Video
Started1637403
Completed1637403
Not completed00

Outcome measures

PrimaryKnowledge & Understanding of Epigenetics Information

We will measure this outcome using a sum score of correct answers for 8 individual items. Scale ranges from 0 points to 8 points with higher scores indicating higher epigenetics knowledge.

Time frame:
After intervention video
Reported as:
Mean · Sum Score of Knowledge Items
Knowledge & Understanding of Epigenetics Information
Sum Score of Knowledge ItemsEpigenetics VideoNanotechnology Video
Knowledge & Understanding of Epigenetics Information5.44 ± 0.134.09 ± 0.28
Statistical analysis
  • Epigenetics Video vs Nanotechnology Video · t-test, 2 sided · p = <0.001 · Mean difference (final values): 1.35 · 95% CI 1.06 to 1.65
SecondaryAcceptability of Epigenetics Information

We will measure this outcome using 3 different constructs including perceived benefits of epigenetic research (items 1-7, ranging from 1 to 5 with higher scores indicating higher perceived benefits), perceived drawbacks of epigenetic research (items 8-10, ranging from 1 to 5 with higher scores indicating higher perceived drawbacks), and acceptance of using epigenetic research in medical support (items 11-13, ranging from 1 to 5 with higher scores indicating higher acceptance of using epigenetic research in medical support). Each item was analyzed separately.

Time frame:
After intervention video
Reported as:
Mean · Points on a survey item
Acceptability of Epigenetics Information
Points on a survey itemEpigenetics Video
1. How beneficial do you think epigenetics research will be for society as a whole?3.8 ± 1
2. How beneficial do you think epigenetics research will be for you personally?3.1 ± 1.2
3. How beneficial do you think epigenetics research will be for improving medical treatments?3.8 ± 1
4. How confident are you that epigenetics research will help fix human health problems and diseases?3 ± 1.1
5. ...Epigenetics research will remove stigma around human health problems and diseases?2.6 ± 1.1
6. How confident are you that epigenetics research will produce medical advances?3.3 ± 1.1
7...Medical advances from epigenetics research will be affordable for most people?1.9 ± 1
8...Epigenetics research will increase stigma around human health problems and diseases?2.2 ± 1
9...will lead to discrimination against those who have potentially harmful epigenetic tags?2.4 ± 1.1
10...will lead to politicians passing laws that tell pregnant people what they can and can't do?2.6 ± 1.3
11. Epigenetics research findings should be used to treat human medical conditions.3.8 ± 1.1
12. Epigenetics research findings should be used to restore health.3.8 ± 1.1
13. Epigenetics research findings should be used to enhance or improve human abilities.3.2 ± 1.4
SecondaryPerceptions of Epigenetic Information

We will measure this outcome using an 6 item scale. Scores range from 1 to 5, with higher scores indicating greater perceptions of epigenetic information.

Time frame:
After intervention video
Reported as:
Mean · Points on an averaged scale
Perceptions of Epigenetic Information
Points on an averaged scaleEpigenetics VideoNanotechnology Video
Perceptions of Epigenetic Information3.79 (3.74 to 3.84)3.42 (3.32 to 3.53)
Statistical analysis
  • Epigenetics Video vs Nanotechnology Video · t-test, 2 sided · p = <0.001 · Mean difference (final values): 0.37 · 95% CI 0.25 to 0.48

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Epigenetics Video———
Nanotechnology Video———

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Epigenetics VideoNanotechnology VideoTotal
Mean48 ± 1750 ± 1748 ± 17
Sex: Female, Male
Sex: Female, Male(Participants)Epigenetics VideoNanotechnology VideoTotal
Female9032071110
Male734196930
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Epigenetics VideoNanotechnology VideoTotal
American Indian or Alaska Native8130111
Asian29676372
Native Hawaiian or Other Pacific Islander9615
Black or African American30689395
White544130674
More than one race19272264
Unknown or Not Reported2090209
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Epigenetics VideoNanotechnology VideoTotal
Hispanic or Latino32187408
Not Hispanic or Latino13163161632
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Epigenetics VideoNanotechnology VideoTotal
United States16374032040
08

Study locations

1 site
  • Washington University School of Medicine
    St Louis, Missouri 63110, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2025 to primary completion in Jul 2025, 1 month.

Results were first posted in Oct 2026, 1 year 2 months after primary completion.

Of 745 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's 1 month is below that.

Counting every sponsor, half of 761 studies reached it within 13 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2025
First posted
Jun 13, 2025
StartActual
Jun 12, 2025
Primary completionActual
Jul 18, 2025
CompletionActual
Jul 18, 2025
Results first posted
Oct 14, 2026
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 14, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedKnowledge & understandingUnderstanding of epigeneticsEpigenetics InformationTime frame: At enrollment → After intervention video
Oct 14, 2026
Secondary outcomes
2 edited
What changed in the outcomes
  • EditedAcceptability of epigenetics informationEpigenetics InformationTime frame: At enrollment → After intervention video
  • EditedPerceptions of epigenetic informationEpigenetic InformationTime frame: At enrollment → After intervention video
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    Results posted
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedKnowledge & understandingUnderstanding of epigeneticsEpigenetics InformationTime frame: At enrollment → After intervention video
    Secondary outcomes 2 edited
    What changed in the outcomes
    • EditedAcceptability of epigenetics informationEpigenetics InformationTime frame: At enrollment → After intervention video
    • EditedPerceptions of epigenetic informationEpigenetic InformationTime frame: At enrollment → After intervention video
    + 3 other changes: index terms, verification date and registry notes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07020234
Responsible party
Sponsor
First posted
Jun 13, 2025
Start date
Jun 12, 2025
Primary completion
Jul 18, 2025
Completion
Jul 18, 2025
Results posted
Oct 14, 2026
Last update
Oct 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion